Publications

  1. Yost KJ, Cheville AL, Weaver AL, Al Hilli M, Dowdy SC. Development and validation of a self-report lower-extremity lymphedema screening questionnaire in women. Phys Ther. 2013 May; 93(5):694-703. Epub 2013 Jan 03. 2294172
    View PubMed
  2. Beaumont JL, Havlik R, Cook KF, Hays RD, Wallner-Allen K, Korper SP, Lai JS, Nord C, Zill N, Choi S, Yost KJ, Ustsinovich V, Brouwers P, Hoffman HJ, Gershon R. Norming plans for the NIH Toolbox. Neurology. 2013 Mar 12; 80(11 Suppl 3):S87-92. 2313168
    View PubMed
  3. Yost KJ, Thompson CA, Eton DT, Allmer C, Ehlers SL, Habermann TM, Shanafelt TD, Maurer MJ, Slager SL, Link BK, Cerhan JR. The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymphoma. 2013 Feb; 54(2):290-7. Epub 2012 Sep 06. 2280842
    View PubMed
  4. Shahgholi L, Yost KJ, Kallmes DF. Correlation of the National Institutes of Health patient reported outcomes measurement information system scales and standard pain and functional outcomes in spine augmentation. AJNR Am J Neuroradiol. 2012 Dec; 33(11):2186-90. Epub 2012 Jun 14. 2252641
    View PubMed
  5. Cheville AL, Yost KJ, Larson DR, Dos Santos K, O'Byrne MM, Chang MT, Therneau TM, Diehn FE, Yang P. Performance of an item response theory-based computer adaptive test in identifying functional decline. Arch Phys Med Rehabil. 2012 Jul; 93(7):1153-60. Epub 2012 Feb 25. 2266938
    View PubMed
  6. Eton DT, Bauer BA, Sood A, Yost KJ, Sloan JA. Patient-reported outcomes in studies of complementary and alternative medicine: problems, solutions, and future directions. Explore (NY). 2011 Sep-Oct; 7(5):314-9. 2189364
    View PubMed
  7. Salsman JM, Yost KJ, West DW, Cella D. Spiritual well-being and health-related quality of life in colorectal cancer: a multi-site examination of the role of personal meaning. Support Care Cancer. 2011 Jun; 19(6):757-64. Epub 2010 Apr 20. 2166954
    View PubMed
  8. Yost KJ, Eton DT, Garcia SF, Cella D. Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol. 2011 May; 64(5):507-16. 2155672
    View PubMed
  9. Hahn EA, Choi SW, Griffith JW, Yost KJ, Baker DW. Health literacy assessment using talking touchscreen technology (Health LiTT): a new item response theory-based measure of health literacy. J Health Commun. 2011; 16 Suppl 3:150-62. 2203735
    View PubMed
  10. Kirschner CV, Yost KJ, Du H, Karshima JA, Arrowsmith SD, Wall LL. Obstetric fistula: the ECWA Evangel VVF Center surgical experience from Jos, Nigeria. Int Urogynecol J. 2010 Dec; 21(12):1525-33. Epub 2010 Aug 11. 2136393
    View PubMed
  11. Smith-Gagen J, Cress RD, Drake CM, Romano PS, Yost KJ, Ayanian JZ. Quality-of-life and surgical treatments for rectal cancer--a longitudinal analysis using the California Cancer Registry. Psychooncology. 2010 Aug; 19(8):870-8. 2112488
    View PubMed
  12. Eisenberg DL, Stika C, Desai A, Baker D, Yost KJ. Providing contraception for women taking potentially teratogenic medications: a survey of internal medicine physicians' knowledge, attitudes and barriers. J Gen Intern Med. 2010 Apr; 25(4):291-7. Epub 2010 Jan 20. 1994471
    View PubMed
  13. Yost KJ, Webster K, Baker DW, Jacobs EA, Anderson A, Hahn EA. Acceptability of the talking touchscreen for health literacy assessment. J Health Commun. 2010; 15 Suppl 2:80-92. 2116214
    View PubMed
  14. Yost KJ, Webster K, Baker DW, Choi SW, Bode RK, Hahn EA. Bilingual health literacy assessment using the Talking Touchscreen/la Pantalla Parlanchina: Development and pilot testing. Patient Educ Couns. 2009 Jun; 75(3):295-301. Epub 2009 Apr 21. 1957345
    View PubMed
  15. Kabbinavar FF, Wallace JF, Holmgren E, Yi J, Cella D, Yost KJ, Hurwitz HI. Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancer. Oncologist. 2008 Sep; 13(9):1021-9. Epub 2008 Sep 05. 1943306
    View PubMed
  16. Yost KJ, Hahn EA, Zaslavsky AM, Ayanian JZ, West DW. Predictors of health-related quality of life in patients with colorectal cancer. Health Qual Life Outcomes. 2008; 6:66. Epub 2008 Aug 25. 1943307
    View PubMed
  17. Yount S, List M, Du H, Yost K, Bode R, Brockstein B, Argiris A, Vokes E, Cohen EE, Campbell B, Valenzuela V, George J, Egan R, Chen J, Meddis D, Cella D. A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores. Qual Life Res. 2007 Dec; 16(10):1615-26. Epub 2007 Oct 06. 1943318
    View PubMed
  18. Nieman CL, Kinahan KE, Yount SE, Rosenbloom SK, Yost KJ, Hahn EA, Volpe T, Dilley KJ, Zoloth L, Woodruff TK. Fertility preservation and adolescent cancer patients: lessons from adult survivors of childhood cancer and their parents. Cancer Treat Res. 2007; 138:201-17. 1943308
    View PubMed
  19. Eton DT, Yost KJ, Cella D. Future trends in patient-reported outcomes assessment for patients with advanced-stage lung cancer receiving targeted therapy. Clin Lung Cancer. 2006 Sep; 8(2):99-109. 1943309
    View PubMed
  20. Beaumont JL, Lix LM, Yost KJ, Hahn EA. Application of robust statistical methods for sensitivity analysis of health-related quality of life outcomes. Qual Life Res. 2006 Apr; 15(3):349-56. 1943310
    View PubMed
  21. Yost KJ, Cella D, Chawla A, Holmgren E, Eton DT, Ayanian JZ, West DW. Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches. J Clin Epidemiol. 2005 Dec; 58(12):1241-51. Epub 2005 Oct 13. 1943311
    View PubMed
  22. Ayanian JZ, Zaslavsky AM, Guadagnoli E, Fuchs CS, Yost KJ, Creech CM, Cress RD, O'Connor LC, West DW, Wright WE. Patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol. 2005 Sep 20; 23(27):6576-86. Epub 2005 Aug 22. 1943312
    View PubMed
  23. Yost KJ, Eton DT. Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience. Eval Health Prof. 2005 Jun; 28(2):172-91. 1943313
    View PubMed
  24. Yost KJ, Haan MN, Levine RA, Gold EB. Comparing SF-36 scores across three groups of women with different health profiles. Qual Life Res. 2005 Jun; 14(5):1251-61. 1943314
    View PubMed
  25. Brucker PS, Yost K, Cashy J, Webster K, Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005 Jun; 28(2):192-211. 1943319
    View PubMed
  26. Yost KJ, Yount SE, Eton DT, Silberman C, Broughton-Heyes A, Cella D. Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI). Breast Cancer Res Treat. 2005 Apr; 90(3):295-8. 1943315
    View PubMed
  27. Yost KJ, Sorensen MV, Hahn EA, Glendenning GA, Gnanasakthy A, Cella D. Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument. Value Health. 2005 Mar-Apr; 8(2):117-27. 1943316
    View PubMed
  28. Eton DT, Cella D, Yost KJ, Yount SE, Peterman AH, Neuberg DS, Sledge GW, Wood WC. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol. 2004 Sep; 57(9):898-910. 1943317
    View PubMed
  29. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes. 2003; 1:79. Epub 2003 Dec 16. 1943320
    View PubMed
  30. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001 Oct; 12(8):703-11. 1943321
    View PubMed